Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2013, Article ID 579136, 8 pages
http://dx.doi.org/10.1155/2013/579136
Research Article

Exploratory Bioinformatics Study of lncRNAs in Alzheimer’s Disease mRNA Sequences with Application to Drug Development

1Queensborough Community College of CUNY, 222-05 56th Avenue Bayside, NY 11364, USA
2Albert Einstein College of Medicine, Department of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA

Received 9 December 2012; Revised 11 March 2013; Accepted 15 March 2013

Academic Editor: Bairong Shen

Copyright © 2013 T. Holden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Tremberger Jr., S. Dehipawala, E. Cheung et al., “Fractal analysis of FOXP2 regulated accelerated conserved non-coding sequences in human fetal brain,” World Academy of Science, Engineering and Technology, no. 67, pp. 881–886, 2012. View at Google Scholar
  2. D. Khaitan, M. E. Dinger, J. Mazar et al., “The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion,” Cancer Research, vol. 71, no. 11, pp. 3852–3862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Ozgür, U. Mert, M. Isin, M. Okutan, N. Dalay, and U. Gezer, “Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells,” Clinical and Experimental Medicine, 2012. View at Publisher · View at Google Scholar
  4. L. Han, K. Zhang, Z. Shi et al., “LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis,” International Journal of Oncology, vol. 40, no. 6, pp. 2004–2012, 2012. View at Google Scholar
  5. M. B. Clark, R. L. Johnston, M. Inostroza-Ponta et al., “Genome-wide analysis of long noncoding RNA stability,” Genome Research, vol. 22, no. 5, pp. 885–898, 2012. View at Google Scholar
  6. R. Johnson, “Long non-coding RNAs in Huntington's disease neurodegeneration,” Neurobiology of Disease, vol. 46, no. 2, pp. 245–254, 2011. View at Google Scholar
  7. C. N. Niland, C. R. Merry, and A. M. Khalil, “Emerging roles for long non-coding RNAs in cancer and neurological disorders,” Frontiers in Genetics, vol. 3, article 25, 2012. View at Google Scholar
  8. V. A. Moran, R. J. Perera, and A. M. Khalil, “Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs,” Nucleic Acids Research, vol. 40, no. 14, pp. 6391–6400, 2012. View at Google Scholar
  9. P. Qi and X. Du, “The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine,” Modern Pathology, vol. 26, pp. 155–165, 2012. View at Publisher · View at Google Scholar
  10. F. Niazi and S. Valadkhan, “Computational analysis of functional long noncoding RNAs reveals lack of peptide-coding capacity and parallels with 3' UTRs,” RNA, vol. 18, no. 4, pp. 825–843, 2012. View at Google Scholar
  11. A. C. Tahira, M. S. Kubrusly, M. F. Faria et al., “Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer,” Molecular Cancer, vol. 10, no. 1, 19 pages, 2011. View at Google Scholar
  12. T. Higuchi, “Approach to an irregular time series on the basis of the fractal theory,” Physica D, vol. 31, no. 2, pp. 277–283, 1988. View at Google Scholar · View at Scopus
  13. T. Holden, R. Subramaniam, R. Sullivan et al., “ATCG nucleotide fluctuation of deinococcus radiodurans radiation genes,” Proceedings of SPIE, vol. 6694, Article ID 669417, 10 pages, 2007. View at Google Scholar
  14. T. Holden, G. Tremberger Jr., P. Marchese et al., “DNA sequance based comparative studies of between non-extremophile and extremophile organisms with implications in exobiology,” Proceedings of SPIE, Article ID 70970Q, 12 pages, 2008. View at Google Scholar
  15. R. Fronczek, S. van Geest, M. Frölich et al., “Hypocretin (orexin) loss in Alzheimer's disease,” Neurobiology of Aging, vol. 33, no. 8, pp. 1642–1650, 2012. View at Google Scholar
  16. Eric M. Reiman, Y. T. Quiroz, A. S. Fleisher et al., “Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study,” Lancet Neurology, vol. 11, no. 12, pp. 1048–1056, 2012. View at Google Scholar
  17. H. H. Marti, “Erythropoietin and the hypoxic brain,” The Journal of Experimental Biology, vol. 207, part 18, pp. 3233–3242, 2004. View at Google Scholar
  18. N. M. Kanaan, T. J. Collier, D. M. Marchionini, S. O. McGuire, M. F. Fleming, and C. E. Sortwell, “Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease,” Brain Research, vol. 1068, no. 1, pp. 221–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Alnaeeli, L. Wang, B. Piknova, H. Rogers, X. Li, and C. T. Noguchi, “Erythropoietin in brain development and beyond,” Anatomy Research International, vol. 2012, Article ID 953264, 15 pages, 2012. View at Publisher · View at Google Scholar
  20. A. L. Sirén, M. Fratelli, M. Brines et al., “Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4044–4049, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Villa, P. Bigini, T. Mennini et al., “Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis,” Journal of Experimental Medicine, vol. 198, no. 6, pp. 971–975, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. S. Athavale, A. S. Petrov, C. Hsiao et al., “RNA folding and catalysis mediated by iron (II),” PLoS One, vol. 7, no. 5, Article ID e38024, 7 pages, 2012. View at Google Scholar
  23. A. Pauli, E. Valen, M. F. Lin et al., “Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis,” Genome Research, vol. 22, no. 3, pp. 577–591, 2012. View at Google Scholar
  24. T. Jonsson, H. Stefansson, S. Steinberg et al., “Variant of TREM2 associated with the risk of Alzheimer's disease,” The New England Journal of Medicine, vol. 368, no. 2, pp. 107–116, 2013. View at Google Scholar
  25. R. Guerreiro, A. Wojtas, J. Bras et al., “TREM2 variants in Alzheimer's disease,” The New England Journal of Medicine, vol. 368, no. 2, pp. 117–127, 2013. View at Google Scholar
  26. H. Neumann and M. J. Daly, “Variant TREM2 as risk factor for Alzheimer's disease,” The New England Journal of Medicine, vol. 368, no. 2, pp. 182–184, 2013. View at Google Scholar
  27. D. W. McVicar and G. Trinchieri, “CSF-1R, DAP12 and beta-catenin: a ménage à trios,” Nature Immunology, vol. 10, no. 7, pp. 681–683, 2009. View at Google Scholar